Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Clinical trial NCT05733598 · RECRUITING

Trial details

NCT number: NCT05733598
Sponsor: Replimune, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Biliary Tract Cancer

Start date: 2024-08-01
Primary completion: 2027-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.